www.fdanews.com/articles/160517-jjs-janssen-loses-11-million-jury-verdict-over-topamax

J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax

November 20, 2013

A jury in Philadelphia ordered Janssen to fork over $11 million over allegations that its seizure drug Topamax caused birth defects.
Bloomberg